3,4-Dimethoxycinnamic Acid as a Novel Matrix for Enhanced In Situ Detection and Imaging of Low-Molecular-Weight Compounds in Biological Tissues by MALDI-MSI

ABSTRACT We analyzed the contributions of different heterotrophic bacterial groups to the uptake of several low-molecular weight compounds during a seasonal cycle on the northwestern Mediterranean coast (Blanes Bay Microbial Observatory). The bacterial assemblage structure had been shown to change substantially year-round for this site, but whether changes in the activities of the different bacterial groups also occurred on the seasonal scale was unknown. Microautoradiography combined with catalyzed reporter deposition fluorescence in situ hybridization was used to analyze the patterns of glucose, amino acid, and ATP uptake by different bacterial groups. Gammaproteobacteria and Bacteroidetes were not very active in the uptake of glucose at any time of the year (<10% of cells were active) compared to Alphaproteobacteria (generally >20% of cells were active). Dissolved free amino acids were taken up considerably by Alphaproteobacteria and Gammaproteobacteria but not by Bacteroidetes. Relatively high percentages of cells of the three broad phylogenetic groups actively took up ATP, which could be related to the important phosphorous limitation of bacterial production during most of the year in Blanes Bay. The contribution of SAR11 to the uptake of the monomers was variable year-round, generally with fewer than 30% of the cells being active. By contrast, Roseobacter were highly overrepresented in the uptake of all the substrates throughout all the year, with more than 50% of cells being active in all the samples and for all substrates. Our results suggest that substantial changes in the activity of some phylogenetic groups of bacteria occur throughout the year.

Download Full-text

Low Molecular Weight Microfibers with Light Sensing Properties

Materiale Plastice ◽

10.37358/mp.17.4.4920 ◽

2017 ◽

Vol 54 (4) ◽

pp. 655-658

Author(s):

Andrei Bejan ◽

Dragos Peptanariu ◽

Bogdan Chiricuta ◽

Elena Bicu ◽

Dalila Belei

Keyword(s):

Molecular Weight ◽

Low Molecular Weight ◽

X Ray Diffraction ◽

Aromatic Rings ◽

X Ray ◽

Force Microscopy ◽

Light Sensing ◽

Sensing Applications ◽

Atomic Force ◽

Low Molecular Weight Compounds

Microfibers were obtained from organic low molecular weight compounds based on heteroaromatic and aromatic rings connected by aliphatic spacers. The obtaining of microfibers was proved by scanning electron microscopy. The deciphering of the mechanism of microfiber formation has been elucidated by X-ray diffraction, infrared spectroscopy, and atomic force microscopy measurements. By exciting with light of different wavelength, florescence microscopy revealed a specific optical response, recommending these materials for light sensing applications.

Download Full-text

Inhibitors of Cholinesterases in Pharmacology: the Current Trends

Mini-Reviews in Medicinal Chemistry ◽

10.2174/1389557519666191018170908 ◽

2020 ◽

Vol 20 (15) ◽

pp. 1532-1542 ◽

Cited By ~ 1

Author(s):

Miroslav Pohanka

Keyword(s):

Molecular Weight ◽

Cholinesterase Inhibitors ◽

Recent Literature ◽

Nerve Agents ◽

Low Molecular Weight ◽

Toxic Compounds ◽

Current Trends ◽

Low Molecular Weight Compounds ◽

Wide Group ◽

Anti Inflammation

Inhibitors of cholinesterases are a wide group of low molecular weight compounds with a significant role in the current pharmacology. Besides the pharmacological importance, they are also known as toxic compounds like military nerve agents. In the pharmacology, drugs for Alzheimer disease, myasthenia gravis and prophylaxis of poisoning by nerve agents can be mentioned as the relevant applications. Besides this, anti-inflammation and antiphrastic drugs are other pharmacological applications of these inhibitors. This review is focused on a survey of cholinesterase inhibitors with known or expected pharmacological impact and indications of their use. Recent literature with comments is provided here as well.

Download Full-text

Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease

Metabolites ◽

10.3390/metabo11010014 ◽

2020 ◽

Vol 11 (1) ◽

pp. 14

Author(s):

Petr G. Lokhov ◽

Dmitry L. Maslov ◽

Steven Lichtenberg ◽

Oxana P. Trifonova ◽

Elena E. Balashova

Keyword(s):

Parkinson’S Disease ◽

Molecular Weight ◽

Parkinson's Disease ◽

High Resolution Mass Spectrometry ◽

Early Stage ◽

Disease Diagnosis ◽

The Body ◽

Low Molecular Weight ◽

Low Molecular Weight Compounds

A laboratory-developed test (LDT) is a type of in vitro diagnostic test that is developed and used within a single laboratory. The holistic metabolomic LDT integrating the currently available data on human metabolic pathways, changes in the concentrations of low-molecular-weight compounds in the human blood during diseases and other conditions, and their prevalent location in the body was developed. That is, the LDT uses all of the accumulated metabolic data relevant for disease diagnosis and high-resolution mass spectrometry with data processing by in-house software. In this study, the LDT was applied to diagnose early-stage Parkinson’s disease (PD), which currently lacks available laboratory tests. The use of the LDT for blood plasma samples confirmed its ability for such diagnostics with 73% accuracy. The diagnosis was based on relevant data, such as the detection of overrepresented metabolite sets associated with PD and other neurodegenerative diseases. Additionally, the ability of the LDT to detect normal composition of low-molecular-weight compounds in blood was demonstrated, thus providing a definition of healthy at the molecular level. This LDT approach as a screening tool can be used for the further widespread testing for other diseases, since ‘omics’ tests, to which the metabolomic LDT belongs, cover a variety of them.

Download Full-text